Shikonin and Its Role in Inducing Ferroptosis in Osteosarcoma Cells
Author Information
Author(s): Huang Rui, Chu Dawei, Shi Jiandang, Xu Ruiqing, Wang Kun
Primary Institution: General Hospital of Ningxia Medical University
Hypothesis
Does shikonin induce ferroptosis in osteosarcoma cells through the Nrf2/xCT/GPX4 regulatory axis?
Conclusion
Shikonin effectively suppresses osteosarcoma cell proliferation by inducing ferroptosis via the Nrf2/xCT/GPX4 pathway.
Supporting Evidence
- Shikonin significantly suppressed osteosarcoma cell proliferation in a dose-dependent manner.
- Ferroptosis was confirmed as a mechanism of action for shikonin in osteosarcoma cells.
- Shikonin treatment led to increased levels of reactive oxygen species and lipid peroxidation in the cells.
- Shikonin downregulated the expression of xCT and GPX4, key proteins involved in ferroptosis.
Takeaway
Shikonin is a natural compound that can help kill cancer cells by making them undergo a special type of cell death called ferroptosis.
Methodology
The study involved in vitro experiments using osteosarcoma cell lines treated with shikonin to assess cell proliferation, ferroptosis markers, and the Nrf2/xCT/GPX4 pathway.
Limitations
The in vivo anti-tumor effect of shikonin remains to be verified.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website